Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Is Alkermes’ Schizophrenia Data Enough To Drive Demand?

Nov 29 2018

• By Joseph Haas

magnetic resonance image (MRI) of the brain human

Related Content

Alkermes' Depression Drug Likely Needs Another Trial After Crushing US Advisory Cmte. Vote

Nov 02 2018

Alkermes soars on positive schizophrenia data

Jan 08 2015

Alkermes ENLIGHTEN Hints At Efficacy Benefit But Weight Profile Still In Balance

Jun 30 2017

Related Companies

Alkermes plc

Eli Lilly and Company

Bristol Myers Squibb Company

Additional Topics

Clinical Trials Research & Development Neurology BioPharmaceutical

More from Clinical Trials

More from R&D

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window